Companies/Arch Biopartners Inc.

Company profile

Arch Biopartners Inc.

OTC: ACHFF · Healthcare · Biotechnology

Canadian filerHQ Toronto, ONReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

13D

FH 10DQ —GM 2SS 53

v0.1 · 45/100 weight · provisional

↑ listing tenure, market scale · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

$114.1k

Rev growth YoY (TTM)

-163.5%

Net income (FY)

-$1.1M

Employees

Market cap

$41.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$1.1M-1.6M CAD2025

Operating income-$1.1M-1.5M CAD2025

Total assets$75.1k104.5k CAD2025

Liabilities$2.9M4.0M CAD2025

Equity-$2.8M-3.9M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

$70.7k

FY19

$50.5k

FY20

$3.1M

FY21

$755.3k

FY22

$1.5M

FY23

$1.6M

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Arch Biopartners Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Elutia Inc52D Covalon Technologies Ltd.78B+Cell Source, Inc.——Park Dental Partners, Inc. Common Stock——

Key facts

CEORichard Gabriel Muruve

SectorHealthcare

IndustryBiotechnology

HeadquartersToronto, ON

ExchangeOTC: ACHFF

Employees6

IPO date2002-04-24

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.